RECRUITINGINTERVENTIONAL
Effects of AD on VI in Patients With CF
Effects of Autogenic Drainage on Ventilation Inhomogeneity in Patients With Cystic Fibrosis
About This Trial
This study will investigate the effects of a chest physiotherapy manual technique (autogenic drainage) on ventilation inhomogeneity in patients with cystic fibrosis. Lung clearance index (LCI) is the primary outcome
Who May Be Eligible (Plain English)
Who May Qualify:
- Cystic fibrosis diagnosis
- FEV1 \> 40%
- Able to sustain 30min of chest physiotherapy
Who Should NOT Join This Trial:
- Presence of Burkoldheria cepacia or non tuberculous mycobacteria
- Orthopedic, neuromuscular or cardiac disorder likely to impact respiratory system
- Need for supplemental oxygen
- Cardiac pacemaker or internal cardiac defibrillator
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Cystic fibrosis diagnosis
* FEV1 \> 40%
* Able to sustain 30min of chest physiotherapy
Exclusion Criteria:
* Presence of Burkoldheria cepacia or non tuberculous mycobacteria
* Orthopedic, neuromuscular or cardiac disorder likely to impact respiratory system
* Need for supplemental oxygen
* Cardiac pacemaker or internal cardiac defibrillator
Treatments Being Tested
OTHER
Autogenic drainage
Autogenic drainage is an airway clearance technique that attempts to obtain the optimal airflow to evacuate the secretions. This technique uses modulation of inspiratory and expiratory airflow at different breathing level within the vital capacity.
DRUG
Aerosoltherapy
Aerosolized drugs are individualized for each participants, in line with current standardized practice in our hospital. Those drugs will not be modified for the purpose of this study.
Locations (1)
Cliniques universitaires Saint-Luc
Brussels, Belgium